Patients living with conditions that historically had few treatment options are now more likely to encounter transformative specialty medications. Growing specialty prescription volume supports the notion that providers see the value in these therapies as well. But often, navigating the process of accessing these specialty brands can be difficult and time-consuming.
In a recent Drug Channels article, “Electronic Prescription Management and Enrollment for Specialty Medications—Expanding Provider Adoption of Tech-Enabled Hub Services,” CoverMyMeds Market Development Director Kyle Grimslid addresses the barriers providers and patients face in the specialty prescription process.
He goes on to discuss how AMP: Access for more Patients™ can enhance access, affordability and adherence—including a reported 27% reduction in time to therapy.
Learn more about how CoverMyMeds and RxCrossroads by McKesson are using technology to solve patients' medication access challenges through AMP: Access for More Patients.